Las Vegas, NV -- (SBWIRE) -- 01/14/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Cooper Tire & Rubber Co(NYSE:CTB), Zogenix, Inc.(NASDAQ:ZGNX), Infinera Corp.(NASDAQ:INFN), Lexicon Pharmaceuticals, Inc.(NASDAQ:LXRX)
Cooper Tire & Rubber Co(NYSE:CTB) was a volume gainer of 2.61 million shares and the average volume of the stock remained 1.88 million shares. The stock opened the session at $25.86 and finished at the end of the day at $24.69 and the stock plunged -4.49%.The market capitalization of the stock remained 1.61 billion. Cooper Tire & Rubber Company, together with its subsidiaries, manufactures and markets replacement tires worldwide. It operates in two segments, North American Tire Operations and International Tire Operations.
Has CTB Found The Bottom And Ready To Gain Momentum? Find Out Here
In the preceding trading session, Zogenix, Inc.(NASDAQ:ZGNX) exchanged 2.60 million shares and the average volume remained 2.51 million shares. The stock closed the session at $4.26 with the drop of -1.16%. Zogenix, Inc., a pharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system disorders and pain. Zogenix, Inc. was founded in 2006 and is headquartered in San Diego, California.
Why Should Investors Buy ZGNX After the Recent Fall? Just Go Here and Find Out
Infinera Corp.(NASDAQ:INFN) decreased -2.86% and its closing price was $9.02. The volume of the stock was 2.59 million shares and the average volume remained 1.23 million shares. The market capitalization of the stock remained 1.08 billion. The beta of the stock remained 1.31. Infinera Corporation provides optical networking equipment, software, and services to communications service providers, Internet content providers, cable operators, and subsea network operators worldwide.
Will INFN Get Buyers Even After The Recent Rally? Find Out Here
Lexicon Pharmaceuticals, Inc.(NASDAQ:LXRX) exchanged 2.53 million shares in the previous trading session, and its average trading remained 1.43 million shares. LXRX dropped -2.50% and it closed the trading at $1.95. The market capitalization of the stock remained 1.00 billion. Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of treatments for human disease. Lexicon Pharmaceuticals, Inc. was founded in 1995 and is headquartered in The Woodlands, Texas.
Has LXRX Found The Bottom and Ready To Move Up? Find Out Here
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)